cervical cancer
Conditions
Interventions
PBMS Group:Pelvic Bone Marrow Sparing Intensity Modulated Radiotherapy
Control group:No
Sponsors
The first hospital of China Medical University
Eligibility
Sex/Gender
All
Age
20 Years to 70 Years
Inclusion criteria
Inclusion criteria: (1) Eligible patients comprised clinical Stage Ib2 - IIIb cervical carcinoma and no previous history of chemotherapy or pelvic irradiation (according to the FIGO clinical stage of 2015 NCCN guidelines); (2) Aged between 20 and 70 years with ECOG score < 3 (as defined by Zubrod-ECOG-WHO); (3) All the patients will be treated with concurrent Cisplatin chemotherapy and IMRT.
Exclusion criteria
Exclusion criteria: (1) Patients or their families refused to participate in this study; (2) Patients treated with extended-field radiation therapy were excluded; (3) Patients who interruped treatment were excluded; (4) Patients who with blood related diseases or occupational exposures such as paint, decoration, nail industry, etc.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| white blood cell count (WBC);Hemoglobin;Absolute neutrophil count;Platelet count; | — |
Countries
China
Contacts
Public ContactLi Guang
The first hospital of China Medical University
Outcome results
None listed